Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

To join this study, participants generally need to be between 18 and 85 years old. Before their stroke, they should have been able to carry out their daily activities without much help. The stroke must be disabling, meaning it affects their ability to do things like bathing or walking, and it needs to be caused by a blockage in a specific type of smaller brain blood vessel that measures at least 1.5mm across. The stroke symptoms must have started within the last 24 hours.

There are also some specific findings on brain scans that would be needed, showing a certain amount of brain tissue at risk from the stroke but not too much damage already done. For some people, particular stroke symptoms like speech problems or vision loss might also be considered.

However, some conditions would mean you can't join. For example, if your brain scans show there's bleeding in the brain, or if you've already had a different procedure to clear the same blood vessel. If there are other blockages that are too difficult to reach, or if the initial stroke was part of a blockage in a much larger vessel, you wouldn't be able to take part.

The study involves evaluating a new treatment called the Tigertriever 13. If you join, you would either receive the Tigertriever 13 treatment or standard medical care. There will be initial brain scans and evaluations when you first come to the hospital. If you receive the Tigertriever 13, a doctor will perform the procedure to try and remove the clot. After this, there will be follow-up appointments and scans over a period of time to monitor your recovery and the effects of the treatment. These check-ups will assess how well you are doing, including your day-to-day abilities and any changes in your stroke symptoms. The total duration of your participation, including all follow-up visits, would be explained to you in detail by the study team.